Commentary on Berlin et al .

Berlin JA Morris S Rockhold F . Bumps and bridges on the road to responsible sharing of clinical trial data. Clin Trials 2014; 11(1): 7–12.

European Medicines Agency. Draft policy 70: Publication and access to clinical-trial data, 2013. Available at: http://www.ema.europa.eu/ema/doc_index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500144730&;murl=menus/document_library/document_library.jsp&mid=0b01ac058009a3dc

Pharmaceutical Research and Manufacturers of America, European Federation of Pharmaceutical Industries and Associations. Principles for responsible clinical trial data sharing, 2013. Available at: http://phrma.org/sites/default/files/pdf/PhRMAPrinciplesForResponsibleClinicalTrialDataSharing.pdf

Nisen P Rockhold F . Access to patient-level data from GlaxoSmithKline clinical trials. N Engl J Med 2013; 369(5): 475–78.

Kmietowicz Z . Roche says it will not relinquish control over access to clinical trial data. BMJ 2013; 346: f1374.

Adams B . LEO Pharma to release clinical trial data. Pharmafile, 2013. Available at: http://www.pharmafile.com/news/181363/leo-pharma-release-clinical-trial-data

Chalmers I. From optimism to disillusion about commitment to transparency in the medico-industrial complex. J R Soc Med 2006; 99(7): 337–41.

Simes RJ . Publication bias: The case for an international registry of clinical trials. J Clin Oncol 1986; 4(10): 1529–41.

Song F Parekh S Hooper L , et al. Dissemination and publication of research findings: An updated review of related biases. Health Technol Assess 2010; 14(8): iii, ix–xi, 1–193.

Huser V Cimino JJ . Linking ClinicalTrials.gov and PubMed to track results of interventional human clinical trials. PLoS One 2013; 8(7): e68409.

Prayle AP Hurley MN Smyth AR . Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: Cross sectional study. BMJ 2012; 344: d7373.

Wieseler B Wolfram N McGauran N . Completeness of reporting of patient-relevant clinical trial outcomes: Comparison of unpublished clinical study reports with publicly available data. PLoS Med 2013; 10(10): e1001526.

Goldacre B . Bad Pharma: How Medicine is Broken, and How We Can Fix It. Fourth Estate, London, 2013.

Bodoni S AbbVie . InterMune sue to block clinical-trial data release. Bloomberg, 2013. Available at: http://www.bloomberg.com/news/2013-03-11/abbvie-sues-eu-regulatorto-block-clinical-trial-data-release.html

AllTrials. Medical researchers denied clinical trial information, 2013. Available at: http://www.alltrials.net/news/medical-researchers-denied-clinical-trial-information/

Vedula SS Li T Dickersin K . Differences in reporting of analyses in internal company documents versus published trial reports: Comparisons in industry-sponsored trials in off-label uses of gabapentin. PLoS Med 2013; 10(1): e1001378.

O’Connor AB . The need for improved access to FDA reviews. JAMA 2009; 302(2): 191–93.

Ware M Mabe M . An Overview of Scientific and Scholarly Journal Publishing. International Association of Scientific, Technical and Medical Publishers, 2012. Available at: http://www.stm-assoc.org/2012_12_11_STM_Report_2012.pdf

Eichler HG Abadie E Breckenridge A . Open clinical trial data for all? A view from regulators. PLoS Med 2012; 9(4): e1001202.

International Anticoagulant Review Group. Collaborative analysis of long-term anticoagulant administration after acute myocardial infarction. Lancet 1970; 295(7640): 203–09.

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S McGale P . Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011; 378(9804): 1707–16.

Williams T van Staa T Puri S . Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource. Ther Adv Drug Saf 2012; 13(2): 89–99.